Holen Sie sich die Stockscreener-App
7.91
5.83%
-0.49
Handel nachbörslich:
7.90
-0.010
-0.13%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt NVAX?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$8.40
Offen:
$8.38
24-Stunden-Volumen:
4.30M
Relative Volume:
0.72
Marktkapitalisierung:
$1.28B
Einnahmen:
$1.08B
Nettoeinkommen (Verlust:
$422.82M
KGV:
3.4693
EPS:
2.28
Netto-Cashflow:
$-637.33M
1W Leistung:
-9.08%
1M Leistung:
-16.38%
6M Leistung:
+23.40%
1J Leistung:
-15.40%
1-Tages-Spanne:
$7.8808
$8.40
1-Wochen-Bereich:
$7.8808
$8.75
52-Wochen-Spanne:
$5.01
$11.55
Novavax Inc Stock (NVAX) Company Profile
Firmenname
Novavax Inc
Sektor
Branche
Telefon
240-268-2000
Adresse
700 QUINCE ORCHARD ROAD, GAITHERSBURG, MD
Vergleichen Sie NVAX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NVAX
Novavax Inc
|
7.91 | 1.36B | 1.08B | 422.82M | -637.33M | 2.28 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Novavax Inc Stock (NVAX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-24 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2025-08-28 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-08-20 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2025-06-17 | Eingeleitet | Citigroup | Sell |
| 2025-02-28 | Eingeleitet | BTIG Research | Buy |
| 2024-07-30 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2024-05-10 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2024-05-10 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2023-08-09 | Hochstufung | B. Riley Securities | Neutral → Buy |
| 2023-04-20 | Herabstufung | TD Cowen | Outperform → Market Perform |
| 2023-03-01 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2023-01-09 | Bestätigt | B. Riley Securities | Buy |
| 2022-12-30 | Bestätigt | H.C. Wainwright | Buy |
| 2022-12-02 | Eingeleitet | Jefferies | Hold |
| 2022-09-22 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2022-05-20 | Eingeleitet | BofA Securities | Underperform |
| 2022-02-23 | Bestätigt | B. Riley Securities | Buy |
| 2022-02-22 | Fortgesetzt | Jefferies | Buy |
| 2022-01-21 | Eingeleitet | Cowen | Outperform |
| 2021-05-12 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-12-14 | Eingeleitet | Jefferies | Buy |
| 2020-08-06 | Bestätigt | H.C. Wainwright | Buy |
| 2020-08-05 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-08-05 | Herabstufung | Ladenburg Thalmann | Neutral → Sell |
| 2020-07-16 | Bestätigt | H.C. Wainwright | Buy |
| 2020-07-08 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2020-06-29 | Bestätigt | B. Riley FBR | Buy |
| 2020-06-29 | Bestätigt | H.C. Wainwright | Buy |
| 2020-06-05 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2020-05-28 | Bestätigt | B. Riley FBR | Buy |
| 2020-05-12 | Bestätigt | H.C. Wainwright | Buy |
| 2020-04-30 | Bestätigt | H.C. Wainwright | Buy |
| 2019-11-27 | Fortgesetzt | B. Riley FBR | Buy |
| 2019-08-14 | Bestätigt | H.C. Wainwright | Buy |
| 2019-02-28 | Herabstufung | Piper Jaffray | Overweight → Underweight |
| 2018-12-18 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2018-12-11 | Eingeleitet | Oppenheimer | Outperform |
| 2018-11-26 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2018-09-21 | Hochstufung | JP Morgan | Underweight → Overweight |
| 2018-03-29 | Hochstufung | Seaport Global Securities | Neutral → Buy |
Alle ansehen
Novavax Inc Aktie (NVAX) Neueste Nachrichten
Why Novavax Inc. stock could rally in 2025Portfolio Return Report & Low Risk High Reward Trade Ideas - newser.com
Top Stocks With Earnings This Week: Joby, IonQ, AMD and More - Benzinga
Relative strength of Novavax Inc. in sector analysis2025 Market Sentiment & Weekly High Return Opportunities - newser.com
Is Novavax Inc. stock in correction or buying zone2025 Trade Ideas & Weekly Momentum Picks - newser.com
How Novavax Inc. stock compares to market leadersMarket Activity Report & Real-Time Stock Price Movement Reports - newser.com
Can Novavax Inc. stock rebound after recent weakness2025 Volatility Report & Weekly High Conviction Trade Ideas - newser.com
How Novavax Inc. (NVV1) stock gains from tech spending2025 Major Catalysts & Growth Focused Entry Reports - newser.com
Key metrics from Novavax Inc.’s quarterly dataSell Signal & Smart Allocation Stock Tips - newser.com
Signal strength of Novavax Inc. stock in tech scanners2025 Earnings Surprises & Technical Buy Zone Confirmations - newser.com
How interest rate cuts could boost Novavax Inc. stockJuly 2025 Big Picture & Reliable Entry Point Trade Alerts - newser.com
Market reaction to Novavax Inc.’s recent newsWeekly Earnings Recap & Real-Time Volume Trigger Notifications - newser.com
Will breakout in Novavax Inc. lead to full recovery2025 Risk Factors & AI Based Buy and Sell Signals - newser.com
Will Novavax Inc. (NVV1) stock benefit from sector leadershipWeekly Profit Analysis & High Conviction Buy Zone Alerts - newser.com
What moving averages say about Novavax Inc.2025 Volume Leaders & Verified Entry Point Signals - newser.com
Novavax (NVAX) to Release Earnings on Thursday - MarketBeat
B. Riley Issues Pessimistic Outlook for Novavax Earnings - MarketBeat
How Novavax Inc. (NVV1) stock moves on employment data2025 Earnings Surprises & Stepwise Trade Signal Implementation - newser.com
Why Novavax Inc. stock remains on watchlistsGold Moves & High Yield Equity Trading Tips - newser.com
Can Novavax Inc. stock reach $100 price targetJuly 2025 Closing Moves & High Yield Stock Recommendations - newser.com
Can Novavax Inc. stock sustain market leadershipPortfolio Return Report & AI Powered Trade Plan Recommendations - newser.com
Novavax (NVAX) Gains Momentum with Sanofi Deal and Analyst Endorsement - MSN
Published on: 2025-10-31 05:03:55 - newser.com
Published on: 2025-10-31 04:02:31 - newser.com
Novavax to Report Third Quarter 2025 Financial Results on November 6, 2025 - Yahoo Finance
The Math Shows PRF Can Go To $51 - Nasdaq
Finanzdaten der Novavax Inc-Aktie (NVAX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):